Medicure Inc. a cardiovascular pharmaceutical company, today announced that it has received notice from the purchaser of Medicure’s interests in Apicore of potential claims against funds held back in respect of representations and warranties under the Apicore sale agreement. The notice does not contain sufficiently detailed information to enable Medicure to assess the merits or size of the claims at this stage. Nevertheless, Medicure will proceed diligently to investigate the potential claims and attempt to satisfactorily resolve them with a view to having the holdback funds released as quickly as possible. In conjunction with the sale of Medicure’s interests in Apicore, representation and warranty insurance was obtained by the purchaser that could result in mitigation of the potential claims.
Date: February 18, 2019
Source: Market Watch